Roche signs Dx development deal with Pacific Biosciences

09/26/2013 | American City Business Journals

Pacific Biosciences of California has struck a deal to develop and sell sequencing tools and consumables exclusively to Roche Diagnostics. Pacific Biosciences will receive $35 million in cash and potentially $40 million more from the deal, which also gives Roche exclusive rights to use the technologies for nucleic acid sequencing for in vitro diagnostics for humans.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC